What is Bio-Rad Laboratories Price-to-Free-Cash-Flow?
As of today (2024-10-31), Bio-Rad Laboratories's share price is $358.19.
Bio-Rad Laboratories's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $10.18. Hence, Bio-Rad Laboratories's Price-to-Free-Cash-Flow Ratio for today is 35.18.
The historical rank and industry rank for Bio-Rad Laboratories's Price-to-Free-Cash-Flow or its related term are showing as below:
BIO'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 17.93 Med: 48.17 Max: 548.92
Current: 58.09
During the past 13 years, Bio-Rad Laboratories's highest Price-to-Free-Cash-Flow Ratio was 548.92. The lowest was 17.93. And the median was 48.17.
BIO's Price-to-Free-Cash-Flow is ranked worse than 69.86% of 345
companies
in the Medical Devices & Instruments industry
Industry Median: 29.54
vs BIO: 58.09
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Bio-Rad Laboratories was 19.50% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -22.10% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was -6.80% per year.
During the past 13 years, Bio-Rad Laboratories's highest 3-Year average Free Cash Flow per Share Growth Rate was 107.70% per year. The lowest was -63.00% per year. And the median was 3.50% per year.
Bio-Rad Laboratories Price-to-Free-Cash-Flow Historical Data
The historical data trend for Bio-Rad Laboratories's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bio-Rad Laboratories's Price-to-Free-Cash-Flow
For the Medical Devices subindustry, Bio-Rad Laboratories's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Rad Laboratories's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Bio-Rad Laboratories's Price-to-Free-Cash-Flow falls into.
Bio-Rad Laboratories's Share Price of today is $358.19. Bio-Rad Laboratories's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.18.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Bio-Rad Laboratories Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Bio-Rad Laboratories's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BIO has been successfully added to your 